Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Illicit / Illicit Gardens is stocked at 278 licensed dispensaries across Missouri, New Jersey, and New York, 181 of them in Missouri, with the deepest coverage in St. Louis, KCMO, Columbia, Springfield, and Cape Girardeau. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Illicit / Illicit Gardens’ mix concentrated in Flower at 38.18% share with year-over-year decline of 17.19% and month-over-month slip of 0.38%, while Vapor Pens rose to 29.45% share with 7.67% YoY growth and 10.26% MoM growth. Pre-Roll expanded to 18.67% share on 31.55% YoY and 2.46% MoM gains, contrasted by Edible at 10.11% share with 2.56% YoY and -0.26% MoM. Smaller lines moved sharply: Concentrates reached 2.65% share on 69.76% YoY and 27.54% MoM growth, and Tincture & Sublingual, though just 0.12% share, spiked 110.72% MoM with 0.49% YoY. With overall brand sales up 20.28% YoY and average price down 3.70%, the pattern implies mix-led growth is offsetting Flower contraction and that July 2026 momentum is coming from inhalables and niche formats rather than pricing.
Positioning-wise, holding rank 3 in Flower in Missouri while Flower declines 17.19% YoY and 0.38% MoM suggests the brand is defending a flagship category even as wallet share migrates toward Vapor Pens (+7.67% YoY, +10.26% MoM) and Pre-Roll (+31.55% YoY, +2.46% MoM). The outsized MoM surges in Concentrates (+27.54%) and Tincture & Sublingual (+110.72%) against small shares (2.65% and 0.12%, respectively) indicate experimentation that can hedge Flower cyclicality, and the 3.70% YoY price reduction paired with 20.28% YoY sales growth signals a volume-led posture. The implication is a dual-track stance: maintain visibility in Flower to monetize rank 3 while leaning into expanding inhalable formats to capture faster-moving demand without overexposing the portfolio to a softening core.
Competitive Landscape
Illicit / Illicit Gardens sits at rank #3 in MO Flower for July 2026 with no year-over-year rank change from #3, while slipping 1 position from #2 in April 2026 to #3 in July 2026, and coming off a peak rank of #2 reached in May 2026; in directional contrast, Sinse Cannabis improved from #4 year-over-year to #2 currently (+2 ranks) as its sales rose 8.99% YoY, and Flora Farms held #1 year-over-year and in July 2026 despite a 1.25% YoY sales decline, indicating that Illicit / Illicit Gardens’ flat YoY rank and recent quarter-over-quarter dip imply stable share retention but limited upward mobility against rivals that are either defending leadership or gaining ground.

Notable Products
Smokos - GMO Cookies Pre-Roll 2-Pack (1g) posted the largest move with a +26.9% month-over-month gain while climbing to rank 5, contrasting with CBD/CBN/THC 2:2:1 Peaches & Dreams Nighttime Gummies 10-Pack (200mg CBD, 200mg CBN, 100mg THC) down -6.8% at rank 4. GMO Cookies (3.5g) in Flower rose +4.0% and held rank 1, whereas Ghost OG (3.5g) slipped -2.1% at rank 2. The pattern implies pre-roll line extensions are accelerating alongside a stable flagship flower, tilting the mix toward convenience formats without displacing top Flower ranks.
Smokos - GMO Cookies Pre-Roll 5-Pack (2.5g) advanced +19.1% at rank 6, while Chem Butter (3.5g) eased -1.2% at rank 7. At least four of the top ten are Flower SKUs by rank positions 1, 2, 3, and 7, while two Smokos pre-rolls sit in ranks 5 and 6, indicating a narrowing gap between Flower and Pre-Roll. The implication is that July 2026 demand is consolidating around GMO/Gorilla Pie genetics across both Flower and Pre-Roll, signaling a portfolio strategy to cross-pollinate strains into multiple formats for share defense.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







